Phase I/II trial of nedaplatin and docetaxel for advanced squamous cell carcinoma of the lung
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2016
At a glance
- Drugs Docetaxel (Primary) ; Nedaplatin (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 04 Mar 2011 Status changed from active, no longer recruiting to completed.
- 04 Mar 2011 Results have been published in Annals of oncology: official journal of the European Society for Medical Oncology.
- 02 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network (Japan) record.